SUN PHARMACEUTICAL INDUSTRIES
Back to Cashflow Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-7,906 Cr | ₹-6,710 Cr | ₹2,376 Cr | ₹-5,193 Cr | ₹-5,980 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-7,906 Cr |
| Mar2024 | ₹-6,710 Cr |
| Mar2023 | ₹2,376 Cr |
| Mar2022 | ₹-5,193 Cr |
| Mar2021 | ₹-5,980 Cr |
How is Cash Flow from Financing Activities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-7,906 Cr | Negative | |
| Mar2024 | ₹-6,710 Cr | Negative | |
| Mar2023 | ₹2,376 Cr | Positive | |
| Mar2022 | ₹-5,193 Cr | Negative | |
| Mar2021 | ₹-5,980 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,292.9 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
| MANKIND PHARMA | ₹102,642.0 Cr | -2% | 2.7% | 7.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 0.5% |
1.5% |
11.9% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses